FDA Clears Solriamfetol (Sunosi) for Narcolepsy, OSA FDA Clears Solriamfetol (Sunosi) for Narcolepsy, OSA
The dual-acting dopamine and norepinephrine reuptake inhibitor showed durable effects in reducing excessive sleepiness in patients with narcolepsy or obstructive sleep apnea.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 21, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

FDA approves Jazz Pharmaceutical sleep disorder drug
The Food and Drug Administration approved Jazz Pharmaceutical's new drug application for Sunosi, a once-daily medicine designed to improve wakefulness in adult patients suffering from narcolepsy and obstructive sleep apnea. Sunosi is expected to be commercially available in the United States following the final scheduling decision by the U.S. Drug Enforcement Administration, which is typically rendered within 90 days of FDA approval. Jazz Pharmaceuticals, which is based in Dublin, Ireland,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 21, 2019 Category: Biotechnology Authors: John George Source Type: news

FDA approves Jazz Pharmaceutical sleep disorder drug
The Food and Drug Administration approved Jazz Pharmaceutical's new drug application for Sunosi, a once-daily medicine designed to improve wakefulness in adult patients suffering from narcolepsy and obstructive sleep apnea. Sunosi is expected to be commercially available in the United States following the final scheduling decision by the U.S. Drug Enforcement Administration, which is typically rendered within 90 days of FDA approval. Jazz Pharmaceuticals, which is based in Dublin, Ireland,… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 21, 2019 Category: American Health Authors: John George Source Type: news

FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 20, 2019 /PRNewswire/ -- Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - March 21, 2019 Category: Drugs & Pharmacology Source Type: news

Medical News Today: Why narcolepsy is an autoimmune condition
New research finds an autoreactive type of immune cell related to narcolepsy, adding to the mounting body of evidence that the condition is autoimmune. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 20, 2019 Category: Consumer Health News Tags: Sleep / Sleep Disorders / Insomnia Source Type: news

FDA decision on Jazz Pharmaceuticals narcolepsy drug expected Wednesday
The Food and Drug Administration is expected to make a decision by Wednesday on a new drug application filed by Jazz Pharmaceuticals for its experimental narcolepsy drug solriamfetol. The FDA was originally set to make a ruling on the application in late December, but its review was extended by three months after the federal agency determined an submission made by Jazz during discussions regarding draft labeling for solriamfetol constituted a "major amendment" to its applicatio n. That resulted in… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 19, 2019 Category: Pharmaceuticals Authors: John George Source Type: news

New proof that narcolepsy is an autoimmune disease
(University of Copenhagen The Faculty of Health and Medical Sciences) Researchers from the University of Copenhagen have discovered autoreactive cells in persons suffering from narcolepsy. This is a new, important proof that the sleep disorder is an autoimmune disease. This knowledge may lead to better treatment of the chronic condition, the researchers behind the new discovery believe. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - March 15, 2019 Category: Biology Source Type: news

Lannett stock up 6 percent following ADHD drug distribution deal
Lannett Co. Inc. entered into an agreement with Elite Pharmaceuticals and SunGen Pharma to be the exclusive U.S. distributor of a generic version of Adderall, a medicine prescribed to treat attention-deficit hyperactivity disorder and narcolepsy. Tim Crew, CEO of Lannett (NYSE: LCI), said the Northeast Philadelphia company plans to launch the generic version of Adderall in the "near term." He added Lannett is hopeful it can expand its relationship with Elite of Northvale, N.J., and SunGen of Princeton,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 11, 2019 Category: Biotechnology Authors: John George Source Type: news

Assessing readiness to drive in adolescents with narcolepsy: what are providers doing? - Ingram DG, Marciarille AM, Ehsan Z, Perry GV, Schneider T, Al-Shawwa B.
PURPOSE: There are no universally accepted guidelines for assessing driving readiness in adolescents with narcolepsy. The purpose of the present study was to survey pediatric sleep medicine providers regarding their current practice patterns for assessing ... (Source: SafetyLit)
Source: SafetyLit - February 11, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

A Third of Americans Are Sleep-Deprived. This Technology Could Help Them Rest Easier
Despite the fact that we spend roughly a third of our lives snoozing (or at least trying to), sleep is not well understood by scientists — to say nothing of the estimated 35% of Americans who don’t get enough of it. Part of the problem is how difficult it is to study slumber. Experiments currently require individuals to come into a hospital or laboratory, cover themselves with an army of electrodes and allow a team of doctors to observe their attempts to drift off. “It’s kind of a nightmare,” says Dr. Emmanuel Mignot, director of the Stanford Center for Sleep Sciences and Medicine. “They...
Source: TIME: Health - January 25, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Artificial Intelligence healthytime Life Reinvented Source Type: news

Nootropics, or ‘Smart Drugs,’ Are Gaining Popularity. But Should You Take Them?
The idea that a pill can supersize human intelligence is decidedly science fiction. But plenty of real-world researchers and drug-makers are working to develop nootropics: pills, supplements and other substances designed to improve various aspects of cognition. A rough translation for the word “nootropic” comes from the Greek for “to bend or shape the mind.” And already, there are dozens of over-the-counter (OTC) products—many of which are sold widely online or in stores—that claim to boost creativity, memory, decision-making or other high-level brain functions. Some of the most popular ...
Source: TIME: Health - January 23, 2019 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Drugs Source Type: news

Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, Dec. 21, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for its new drug application (NDA) for solriamfetol as a treatment to... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 21, 2018 Category: Drugs & Pharmacology Source Type: news

Sleep Disorder Drug May Be Effective for Stimulant Abuse Sleep Disorder Drug May Be Effective for Stimulant Abuse
Modafinil, a wakefulness-promoting agent approved for narcolepsy, obstructive sleep apnea, and shift work sleep disorder, shows promise in treating stimulant use disorders.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2018 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, Nov. 9, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency for solriamfetol, a selective dopamine... Biopharmaceuticals, Regulatory Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 9, 2018 Category: Pharmaceuticals Source Type: news

Solriamfetol Effective for Excessive Sleepiness in OSA, Narcolepsy Solriamfetol Effective for Excessive Sleepiness in OSA, Narcolepsy
The experimental drug solriamfetol appears to keep sleepy patients with narcolepsy or obstructive sleep apnea (OSA) awake and alert, according to an industry-sponsored trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

FDA Approves Sodium Oxybate (Xyrem) for Pediatric Narcolepsy FDA Approves Sodium Oxybate (Xyrem) for Pediatric Narcolepsy
The FDA has approved expanded labeling for sodium oxybate (Xyrem) to include treatment of cataplexy or excessive daytime sleepiness in pediatric narcolepsy.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 29, 2018 Category: Consumer Health News Tags: Family Medicine/Primary Care News Alert Source Type: news

FDA Approves Xyrem (sodium oxybate) for Cataplexy and Excessive Daytime Sleepiness in Pediatric Patients with Narcolepsy
October 27, 2018 -- Today, the U.S. Food and Drug Administration (FDA) approved Xyrem (sodium oxybate) for the treatment of cataplexy and excessive daytime sleepiness (EDS) in pediatric patients (7 to 17 years old) with narcolepsy. Xyrem is a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 27, 2018 Category: Pharmaceuticals Source Type: news

Schoolgirl, 14, falls asleep up to 10 times a day and becomes paralysed when she laughs
Nicole Hirst, from Wakefield in Yorkshire, has narcolepsy, which means her brain cannot properly regulate when she falls asleep, leading to her nodding off multiple times a day. (Source: the Mail online | Health)
Source: the Mail online | Health - September 11, 2018 Category: Consumer Health News Source Type: news

What is the Difference Between Nightmares and Night Terrors?
Discussion Sleep disorders are common in all ages particularly with sleep deprivation in our increasingly busy world. Sleep problems are more common in patients with attention deficit hyperactivity disorder, epilepsy, headache and visual impairments. Sleep problems can cause cognitive and behavioral impairments including emotional regulation problems, increased seizures or headaches, and impaired attention and have been known to prolong recovery from various acquired brain injuries. Parasomnias are “undesirable events that accompany sleep and typically occur during sleep-wake transitions.” The term sleep terr...
Source: PediatricEducation.org - August 27, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Personal trainer with narcolepsy mistaken for a drunk
Belle Hutt, 23, who lives in Amsterdam, became a personal trainer after giving up her dream of working as an interior designer because she couldn't stay awake long enough for an office job. (Source: the Mail online | Health)
Source: the Mail online | Health - August 23, 2018 Category: Consumer Health News Source Type: news

U.S. court denies Jazz Pharma bid to revive narcolepsy drug patents
A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, giving Amneal Pharmaceuticals Inc a boost in its effort to launch a generic version of the medicine. (Source: Reuters: Health)
Source: Reuters: Health - July 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

U.S. court denies Jazz Pharma bid to revive patents on narcolepsy drug
A U.S. appeals court on Friday ruled invalid patents owned by Jazz Pharmaceuticals PLC covering its narcolepsy drug Xyrem, opening the door for Amneal Pharmaceuticals Inc to launch a generic version of the medicine. (Source: Reuters: Health)
Source: Reuters: Health - July 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Did the 2009 flu vaccine give some people narcolepsy?
Following the 2009 H1N1 or swine flu pandemic, scientists saw an increase in narcolepsy cases in countries where an immune system booster was use in shots. Now, the US stockpiles it. (Source: the Mail online | Health)
Source: the Mail online | Health - July 5, 2018 Category: Consumer Health News Source Type: news

Change in brain cells linked to opiate addiction, narcolepsy
This study was supported by grants from the National Institute on Drug Abuse and the Medical Research Service of the U.S. Department of Veterans Affairs. (Source: UCLA Newsroom: Health Sciences)
Source: UCLA Newsroom: Health Sciences - June 27, 2018 Category: Universities & Medical Training Source Type: news

Change in brain cells linked to opiate addiction, narcolepsy
(University of California - Los Angeles) Two discoveries -- one in the brains of people with heroin addiction and the other in the brains of sleepy mice -- shed light on chemical messengers in the brain that regulate sleep and addiction. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 27, 2018 Category: International Medicine & Public Health Source Type: news

A wakefulness molecule is abundant in the brains of heroin addicts
(American Association for the Advancement of Science) Researchers have discovered that the brains of heroin addicts harbor a greater number of neurons that produce hypocretin, a molecule involved in arousal and wakefulness, and one lacking in abundance in people with narcolepsy. In mice with narcolepsy, these researchers went on to show, administering morphine -- an opioid similar. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 27, 2018 Category: International Medicine & Public Health Source Type: news

What is the Prevalence of Somnambulism?
Discussion Sleep disorders are common in all ages particularly sleep deprivation in our increasingly busy world. A review of health problems caused by inadequate sleep can be found here. Sleep problems are more common in patients with attention deficit hyperactivity disorder, epilepsy, headache and visual impairments. Sleep problems can cause cognitive and behavioral impairments including emotional regulation problems, increased seizures or headaches, and impaired attention and has been known to prolong recovery from various acquired brain injuries. Somnambulism or sleepwalking is a parasomnia (which include confusional a...
Source: PediatricEducation.org - June 25, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medical News Today: What is Evekeo?
Evekeo is an amphetamine-based medication that is used to treat narcolepsy, ADHD, and excess weight. Evekeo is the trade name as there is no generic amphetamine drug. It is a controlled substance, due to the risk of dependence and adverse effects. Find out more about this drug, its uses, and the risks involved. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 20, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

New Drug for Narcolepsy, Sleep Apnea on the Horizon New Drug for Narcolepsy, Sleep Apnea on the Horizon
Solriamfetol showed durable effects in reducing excessive sleepiness in patients with narcolepsy or obstructive sleep apnea in a long-term study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 12, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Harmony's lead new drug candidate receives 2 FDA designations
The experimental therapy is being developed to treat cataplexy and narcolepsy. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 31, 2018 Category: American Health Authors: John George Source Type: news

From narcolepsy to apnoea: the science of sleep disorders
Biologist and narcoleptic Henry Nicholls explores what happens when sleep goes wrong (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 24, 2018 Category: Pharmaceuticals Source Type: news

Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2
(MedPage Today) -- Higher dosages showed greater improvements (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - April 25, 2018 Category: Psychiatry Source Type: news

Novel Agent Significantly Curbs Excessive Sleepiness in Narcolepsy Novel Agent Significantly Curbs Excessive Sleepiness in Narcolepsy
A novel agent currently in development helps those with type 1 or type 2 narcolepsy experience less excessive sleepiness, enabling them to maintain wakefulness for longer periods.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 25, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: Coping with an Adderall crash
Adderall is a stimulant medication that is used to treat ADHD or narcolepsy. When a person stops taking Adderall too quickly, they can experience withdrawal symptoms, such as sleep problems or depression. Here, we look at the causes and timeline of an Adderall crash and give tips and remedies for coping if it happens. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 13, 2018 Category: Consumer Health News Tags: ADHD / ADD Source Type: news

Study points to potential misuse/abuse of ADHD drugs
(Wiley) A new British Journal of Clinical Pharmacology study indicates that methylphenidate, a central nervous system stimulant approved to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, may be subject to misuse and/or abuse. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 7, 2018 Category: International Medicine & Public Health Source Type: news

Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company's New Drug Application (ND... Biopharmaceuticals, FDA Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 2, 2018 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 2, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing with standard review the company's New Drug Application (NDA) seeking marketing... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 2, 2018 Category: Drugs & Pharmacology Source Type: news

Narcolepsy causes woman to pass out every time she laughs
Sam Hart, 20, from Luton, suffers from  narcolepsy, which has left her 'robbed of her independence' and with 'hardly any quality of life'. She is unable to take medication after it made her want to start fires. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2018 Category: Consumer Health News Source Type: news

‘Narcolepsy isn’t funny’ – living with a sleep disorder
The journalist and author Henry Nicholls has been struggling with several sleep disorders for decades, but for many it ’s just a jokeFor a serious examination of the devastating and incurable disability that isnarcolepsy, Henry Nicholls ’s book,Sleepy Head,is a surprisingly funny account.There is the obvious, if somewhat cruel, humour to be found in stories of people falling asleep in surprising places: in a small boat sailing around theFarne Islands, with the freezing North Sea cascading over the gunwale; while scuba diving; on a rollercoaster; at the dentist ’s; on the back of a horse; on a surfboard. B...
Source: Guardian Unlimited Science - February 25, 2018 Category: Science Authors: Amelia Hill Tags: Sleep Sleep apnoea Life and style Psychology Science Health & wellbeing Society Source Type: news

A share in the future of DNA sequencing
Professor George Church on why he wants us to earn money by sharing our genomic data, his plans to resurrect the woolly mammoth and how narcolepsy helps him generate ideas• How can I make money from my DNA?A new genetic testing company calledNebula Genomics wants to help people profit from their own genomes. The Observer talks to Harvard University DNA sequencing pioneer George Church about his latest venture, what ’s cooking in his lab and how falling asleep on the job can sometimes be a godsend.What is the value of getting your genome sequenced? Why do it?One very compelling argument that I think justifies alm...
Source: Guardian Unlimited Science - February 18, 2018 Category: Science Authors: Zo ë Corbyn Tags: Genetics Science Biology Medical research Stem cells Source Type: news

George Church: "Genome sequencing is like the internet back in the late 1980s."
The pioneering geneticist on why he wants us to earn money by sharing our genomic data, his plans to resurrect the woolly mammoth and how narcolepsy helps him generate ideas• How can I make money from my DNA?A new genetic testing company calledNebula Genomics wants to help people profit from their own genomes. The Observer talks to Harvard University DNA sequencing pioneer George Church about his latest venture, what ’s cooking in his lab and how falling asleep on the job can sometimes be a godsend.What is the value of getting your genome sequenced? Why do it?One very compelling argument that I think justifies a...
Source: Guardian Unlimited Science - February 18, 2018 Category: Science Authors: Zo ë Corbyn Tags: Genetics Science Biology Medical research Stem cells Source Type: news

Sleepless in Latin America: Blind cavefish, extreme environments and insomnia
(Florida Atlantic University) A study led by researchers from Florida Atlantic University has found that differences in the production of the neuropeptide Hypocretin, previously implicated in human narcolepsy, may explain variation in sleep between animal species, or even between individual people. It may also provide important insight into the evolution of sleep and how we might build a brain that does not need to sleep. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2018 Category: International Medicine & Public Health Source Type: news

Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
DUBLIN, Dec. 21, 2017 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration on December 20, 2017 seeking marketing appro... Biopharmaceuticals, FDA Jazz Pharmaceuticals, solriamfetol, narcolepsy, obstructive sleep apnea (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 21, 2017 Category: Pharmaceuticals Source Type: news

Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea
DUBLIN, Dec. 21, 2017 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration on December 20, 2017 seeking marketing approval for solriamfetol... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - December 21, 2017 Category: Drugs & Pharmacology Source Type: news

Correlates to problem behaviors in pediatric narcolepsy: a pilot study - Shelton AR, Malow B.
STUDY OBJECTIVE: Excessive daytime sleepiness, the hallmark of narcolepsy, predisposes patients to serious performance decrements in multiple areas of function. Psychosocial dysfunction has been demonstrated in adults and children with narcolepsy. Several ... (Source: SafetyLit)
Source: SafetyLit - November 13, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

The science of sleep: Finding a cure for narcolepsy
One of my first jobs was to keep a lookout for lions. (Source: CNN.com - Health)
Source: CNN.com - Health - October 24, 2017 Category: Consumer Health News Source Type: news

Dreaming of a cure: the battle to beat narcolepsy
A global struggle to find the cause of the rare condition that causes uncontrollable sleepiness has a long and strange history, but there ’s hope of a cure at handOne of my first jobs was to keep a lookout for lions. There are some occupations that are not suitable for someone with untreated narcolepsy and this is probably one of them. I was 22, a recent zoology graduate studying meerkats in the Kalahari desert in South Africa. We worked in pairs, one of us on foot, walking with meerkats, the other in the jeep scanning the horizon for danger. On many occasions, I awoke with the imprint of the steering wheel on my for...
Source: Guardian Unlimited Science - October 22, 2017 Category: Science Authors: Henry Nicholls Tags: Neuroscience Sleep Health & wellbeing Life and style Source Type: news

Newly formed Montco biopharm firm raises $270M
The company also obtained the U.S. rights to a narcolepsy drug from a French pharmaceutical developer. (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - October 6, 2017 Category: Health Management Authors: John George Source Type: news

Narcolepsy (Definition, Symptoms, Treatment, Medication)
Title: Narcolepsy (Definition, Symptoms, Treatment, Medication)Category: Diseases and ConditionsCreated: 3/4/2002 12:00:00 AMLast Editorial Review: 10/2/2017 12:00:00 AM (Source: MedicineNet Sleep General)
Source: MedicineNet Sleep General - October 2, 2017 Category: Sleep Medicine Source Type: news